Yanai Shlomo 4
4 · Amneal Pharmaceuticals, Inc. · Filed May 10, 2022
Insider Transaction Report
Form 4
Yanai Shlomo
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2022-05-08+35,406→ 89,146 total - Exercise/Conversion
Restricted Stock Units
2022-05-08−35,406→ 0 total→ Class A Common Stock (35,406 underlying) - Award
Restricted Stock Units
2022-05-09+80,128→ 80,128 total→ Class A Common Stock (80,128 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022.
- [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.